1. Biswas, Asok; SETIA, Namrata; BHAWAN, Jag. Cutaneous Neoplasms With Prominent Verocay Body–Like Structures: The So-called “Rippled Pattern”. The American journal of dermatopathology, v. 33, n. 6, p. 539-550, 2011.
  2. Calonje E, Brenn T, Lazar A and McKee PH. McKee’s Pathology of the skin with clinical correlations. Fourth Edition. Sunders – Elsevier Inc. St. Louis, Missouri – USA, 2012.
  3. Elder DE, Elenitsas R, Rosenbach M, Murphy GF, Rubin AI and Xu X. Lever’s histopathology of the skin. Philadelphia – USA: Wolters Kluwer, Eleventh ed., 2015.
  4. Juan, J. San et al. Basal cell carcinoma with prominent central palisading of epithelial cells mimicking schwannoma. Journal of cutaneous pathology, v. 26, n. 10, p. 528-532, 1999.
  5. Kadono, T. et al. Basal cell carcinoma with neuroid type nuclear palisading: a report of three cases. The British journal of dermatology, v. 138, n. 6, p. 1064, 1998.
  6. Requena L and Sangüeza O. Sebaceous Adenoma and sebaceoma, cap 68 in Cutaneous Adnexal Neoplasms. Springer 2017, p. 881-922.
  7. Weedon D. Weedon‘s Skin Pathology. Churchill Livingstone/Elsevier, Third edition, 2010.
  8. Wick MR et al. Sebaceoma in Elder DE, Massi D, Scolyer RA and Willemze R, editors. WHO classification of skin tumors. 4th ed. 2018 – p.213-214.
  9. Louis DN, et al. WHO Classification of Tumours of Central Nervous System, 8ed, Lyon, 2016.
  10. Bioulac-Sage P, Sempoux C, Frulio N, et al. Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes. Clin Res Hepatol Gastroenterol. 2019;43(1):12-19. doi:10.1016/j.clinre.2018.07.007.
  11. Bossen L, Grønbaek H, Lykke Eriksen P, Jepsen P. Men with biopsy-confirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: A nationwide population-based study. Liver Int. 2017;37(7):1042-1046. doi:10.1111/liv.13423.
  12. Choi WT, Kakar S. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features. Adv Anat Pathol. 2018;25(4):254-262. doi:10.1097/PAP.0000000000000189.
  13. Hu M, Liu W, Yin F, Zhang D, Liu X, Lai J. Liver Metastasis of Hepatoid Colonic Adenocarcinoma: A Rare and Unusual Entity With Poor Prognosis and Review of the Literature. Gastroenterology Res. 2018;11(6):430-435. doi:10.14740/gr1097.
  14. Khanna M, Ramanathan S, Fasih N, Schieda N, Virmani V, McInnes MD. Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma. Insights Imaging. 2015;6(3):347-362. doi:10.1007/s13244-015-0399-8.
  15. Klompenhouwer AJ, IJzermans JNM. Malignant potential of hepatocellular adenoma. Liver Int. 2017;37(7):966-967. doi:10.1111/liv.13449.
  16. Renzulli M, Clemente A, Tovoli F, Cappabianca S, Bolondi L, Golfieri R. Hepatocellular adenoma: An unsolved diagnostic enigma. World J Gastroenterol. 2019;25(20):2442-2449. doi:10.3748/wjg.v25.i20.2442.
  17. Roncalli M, Sciarra A, Tommaso LD. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma. Clin Mol Hepatol. 2016;22(2):199-211. doi:10.3350/cmh.2016.0101.
  18. Terracciano LM, Glatz K, Mhawech P, et al. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol. 2003;27(10):1302-1312. doi:10.1097/00000478-200310000-00002.
  19. Sempoux C, Balabaud C, Bioulac-Sage P. Pictures of focal nodular hyperplasia and hepatocellular adenomas. World J Hepatol. 2014;6(8):580-595. doi:10.4254/wjh.v6.i8.580.
  20. Su JS, Chen YT, Wang RC, Wu CY, Lee SW, Lee TY. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol. 2013;19(3):321-327. doi:10.3748/wjg.v19.i3.321.
  21. Margaux Sala, Delphine Gonzales, Thierry Leste‐Lasserre, Nathalie Dugot‐Senant, Valérie Paradis, et al. ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice. Hepatology Communications 2020;4:809-824 . doi:10.1002/hep4.1514.
  22. Turri-Zanoni M, Maragliano R, Battaglia P, et al. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival. Oral Oncol. 2017; 74:21-29.
  23. Neuroectodermal / melanocytic tumours. In: Pathology and genetics of head and neck tumours, Adel K. El-Naggar,John K.C. Chan, Jennifer R. Grandis, TakashiTakata & Pieter J. Slootweg (Eds), IARC Press, Lyon, France 2017.
  24. Czapiewski P, Gorczyński A, Haybaeck J, et al. Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma. Pol J Pathol. 2016;67(2):130-135.
  25. Ozsahin M et al: Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study. Int J Radiat Oncol Biol Phys.2010; 78(4):992-7.
  26. Bishop JA, Thompson LD, Cardesa A, et al. Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma. Head Neck Pathol. 2015; 9(4):507-518.
  27. Goldblum, John R., Sharon W. Weiss, and Andrew L. Folpe. Enzinger and Weiss’s soft tissue tumors, 7th ed. Elsevier Health Sciences, 2020.
  28. Hornick, Jason L. Practical soft tissue pathology: a diagnostic approach: a volume in the pattern recognition series. Elsevier Health Sciences, 2017.
  29. Goldblum, John R., et al. Rosai and Ackerman’s Surgical Pathology E-Book. Elsevier Health Sciences, 2017.
  30. WHO Classification of Tumours of Soft Tissue and Bone. WHO Classification of Tumours, 4th Edition, Volume 5, 2013.
  31. Zhou, Ming, George J. Netto, and Jonathan I. Epstein. Uropathology: High-Yield Pathology. Philadelphia: Elsevier/Saunders, 2012.
  32. Zhou, Ming, and Cristina Magi-Galluzzi. Genitourinary Pathology. Philadelphia: Elsevier Saunders, 2015.
  33. Who Classification of Tumours of the Urinary System and Male Genital Organs. Lyon: International agency for research on cancer, 2016.
  34. Ehdaivand S., M.D. Topic Completed: 1 December 2012, Revised: 9 March 2020, Copyright: 2002-2020, disponível em: http://www.pathologyoutlines.com/topic/ovarytumorgctadult.html.
  35. Bezerra, A.L.R e Lorenzato, F.R.B. Tumores das células da granulosa dos ovários: estudo de 24 casos – Rev. Bras. Ginecol. Obstet. vol.26 no.8 Rio de Janeiro, Sept. 2004.
  36. ALEJO, M. et al. Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases. Papillomavirus Res, v. 5, p. 134-142, Jun 2018.
  37. ATTIPOE, M. F.; STURGIS, C. D. Small cell carcinoma of the uterine cervix in a pregnant patient diagnosed with liquid based cytology and cell block immunocytochemistry. Case Rep Pathol, v. 2014, p. 971464, 2014.
  38. GARDNER, G. J.; REIDY-LAGUNES, D.; GEHRIG, P. A. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol, v. 122, n. 1, p. 190-8, Jul 2011.
  39. KHALBUSS, W. E.; PANTANOWITZ, L.; MONACO, S. E. Cytomorphology of unusual primary tumors in the Pap test. Cytojournal, v. 10, p. 17, Aug 30 2013.
  40. KURMAN, R. et al. Tumors of the cervix, vagina and vulva. AFIP Atlas of Tumor Pathology. Armed Forces Institute of Pathlogy, Washington DC, v. 197, 2010.
  41. NAYAR, R.; WILBUR, D. C. The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes. Springer, 2015.
  42. REICHERT, R. A. Diagnostic gynecologic and obstetric pathology: an atlas and text. Lippincott Williams & Wilkins, 2012.
  43. TEMPFER, C. B. et al. Neuroendocrine carcinoma of the cervix: a systematic review of the literature. BMC Cancer, v. 18, n. 1, p. 530, May 2018.
Referências de edições anteriores